Melbourne Institute of Applied Economic and Social Research - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 13
  • Item
    Thumbnail Image
    Editors' Report 2016
    Williams, R ; Jensen, P ; McDonald, I (WILEY, 2017-06)
  • Item
    Thumbnail Image
    Research Funding Mechanisms and Biomedical Research Outputs
    Clark, J ; Hirsch, G ; Jensen, PH ; Webster, E (WILEY, 2016-06)
    We use scientist‐level panel data in order to estimate the effect which the number, type and source of research grants has on subsequent commercial contracts, publications and patent outputs. In so doing, we control for time‐invariant factors including individual researcher preferences, the nature of the work and the business model of the researcher's laboratory. We find that, whereas Fellowships and Project or program grants had a positive effect on whether the scientist subsequently signed a commercial contract, Equipment and Development grants had the largest impact per grant. Finally, we find that International grants were negatively associated with the number of commercial contracts signed. The data were drawn from 488 biomedical researchers at the Walter and Eliza Hall Institute over the period 2009–2012.
  • Item
    Thumbnail Image
    TM-Link: An Internationally Linked Trademark Database
    Petrie, S ; Adams, M ; Mitra-Kahn, B ; Johnson, M ; Thomson, R ; Jensen, P ; Palangkaraya, A ; Webster, E (Wiley, 2020-06-01)
    This article describes a new database—TM‐Link—that contains 12 million trademark applications and registrations across six jurisdictions. A feature of the database is the identification of trademark equivalents (or families) within and across national trademark offices. Equivalent trademarks are two, or more, insignias for the same product applied for by the same company. Unlike patents, the incentive to file for global priority is comparatively weak since legal priority for trademarks is territorial. To identify the number of true trademark equivalents we therefore create synthetic links using a neural network‐based machine learning algorithm.
  • Item
    No Preview Available
    U21 Ranking of National Higher Education Systems 2015
    WILLIAMS, R ; Leahy, A ; de Rassenfosse, G ; Jensen, P (Universitas 21, 2015)
  • Item
  • Item
    Thumbnail Image
    Innovation and the determinants of company survival
    Buddelmeyer, H ; Jensen, PH ; Webster, E (OXFORD UNIV PRESS, 2010-04)
  • Item
    Thumbnail Image
    Contract Type and the Cost of Provision: Evidence from Maintenance Service Contracts
    Jensen, PH ; Stonecash, RE (WILEY-BLACKWELL PUBLISHING, INC, 2009-06)
    Abstract More than half a billion dollars are spent each year on the maintenance of Australia's urban water and sewerage networks. Expenditure is governed through a mix of in‐house and outsourced maintenance service contracts. We re‐examine issues relating to the relationship between the cost of maintenance service provision and the type of contract used. We take advantage of the fact that water retailers in Melbourne use a mix of contract types – including fixed‐price (FP) and cost‐plus (C+) contracts – for the provision of water and sewerage network maintenance services. Our results suggest that the C+ contract results in substantial savings.
  • Item
    Thumbnail Image
    HOSPITAL TYPE AND PATIENT OUTCOMES: AN EMPIRICAL EXAMINATION USING AMI READMISSION AND MORTALITY RECORDS
    Jensen, PH ; Webster, E ; Witt, J (WILEY, 2009-12)
    This paper investigates whether there are differences in patient outcomes across different types of hospitals using patient-level data on readmission and mortality associated with acute myocardial infarction (AMI). Hospitals are grouped according to their ownership type (private, public teaching, public non-teaching) and their location (metropolitan, country and remote country). Using data collected from 130 Victorian hospitals on 19,000 patients admitted to a hospital with their first AMI between January 2001 and December 2003, we consider how the likelihood of unplanned re-admission and mortality varies across hospital type. We find that there are significant differences across hospital types in the observed patient outcomes - private hospitals persistently outperform public hospitals.
  • Item
    Thumbnail Image
    THE EFFECTS OF AN INCENTIVE PROGRAM ON QUALITY OF CARE IN DIABETES MANAGEMENT
    Scott, A ; Schurer, S ; Jensen, PH ; Sivey, P (WILEY-BLACKWELL, 2009-09)
    An incentive program for general practitioners to encourage systematic and igh-quality care in chronic disease management was introduced in Australia in 1999. There is little empirical evidence and ambiguous theoretical guidance on which effects to expect. This paper evaluates the impact of the incentive program on quality of care in diabetes, as measured by the probability of ordering an HbA1c test. The empirical analysis is conducted with a unique data set and a bivariate probit model to control for the self-selection process of practices into the program. The study finds that the incentive program increased the probability of an HbA1c test being ordered by 20 percentage points and that participation in the program is facilitated by the support of Divisions of General Practice.
  • Item
    Thumbnail Image
    ANOTHER LOOK AT THE RELATIONSHIP BETWEEN INNOVATION PROXIES
    Jensen, PH ; Webster, E (WILEY, 2009-09)
    Shortcomings in the treatment of intangible investment in company accounts imply that there is no statistical collection for innovative activity which abides by the logic used for other economic activity data. As a consequence, analysts rely on innovation proxies derived from administrative and survey data. However, it is still unclear exactly how the different proxies are correlated, and whether the choice amongst different proxies matters. In the light of the innovation measurement, this paper takes another look at the relationship between different proxies of firm innovation. The results show that firm‐level correlations between survey‐based indicators and other proxies for innovation are highest for manufacturing firms and for product innovations.